GT Biopharma Inc. (NASDAQ: GTBP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT GT BIOPHARMA INC.

GT Biopharma Inc. (NASDAQ: GTBP)
Listen to this Section


$0.45
-0.0187 ( -3.99% ) 826.8K

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE ® NK cell engager platform. Our TriKE ® platform is designed to harness and enhance the cancer killing abilities of a patient's immune system's natural killer cells. GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE ® technology.

Market Data


Open $0.45
Previous Close $0.47
Volume 826.8K
Market Cap $16.90M
Day Range $0.45 - $0.48
52 Week Range $0.26 - $3.85
Shares Outstanding 36.06M
Change % -3.99%
Net Change ▼ -0.0187
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -400,000.00

Date Type Amount Purchased Purchaser
2023-08-15 Sale -200000.00 Ohri Manu
2023-08-15 Sale -200000.00 Breen Michael Martin

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Apr 07, 2026
10-q/a Quarterly Reports 75 Mar 06, 2026
10-q/a Quarterly Reports 75 Mar 06, 2026
8-k 8K-related 12 Mar 02, 2026
10-k Annual reports 82 Mar 02, 2026
424b3 Other 2 Jan 30, 2026
s-1 Registration statements 17 Jan 21, 2026
424b3 Other 1 Jan 08, 2026
424b3 Other 2 Dec 02, 2025
8-k 8K-related 12 Nov 26, 2025

Latest News


× Before browsing our site, please accept our cookies policy